A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Myelodysplastic Syndromes · Acute Myeloid Leukemia · Myelodysplastic Syndrome/Neoplasm · Chronic Myelomonocytic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Keck School of Medicine of USC, Los Angeles, California, United States

  • UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange, California, United States

  • Yale University, New Haven, Connecticut, United States

  • University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida, United States

  • University of Emory - Winship Cancer Institute, Atlanta, Georgia, United States

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

  • John Theurer Cancer Center / Hackensack University, Hackensack, New Jersey, United States

  • Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States

  • New York University Langone Hospital - Long Island, Mineola, New York, United States

  • Perlmutter Cancer Center - 34th Street, New York, New York, United States

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • Weill Cornell Medical Center, New York, New York, United States

  • Montefiore Medical Center, The Bronx, New York, United States

  • Duke University, Durham, North Carolina, United States

  • Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus, Ohio, United States

  • Oregon Health and Science University, Portland, Oregon, United States

  • Oregon Oncology Specialists, Salem, Oregon, United States

  • Hollings Cancer Center, Charleston, South Carolina, United States

  • Vanderbilt University Medical Center, Nashville, Tennessee, United States

  • Baylor Research Institute dba Baylor Scott & White Research Institute, Dallas, Texas, United States

  • University of Texas Southwestern Medical Center, Dallas, Texas, United States

  • MD Anderson Cancer Center, Houston, Texas, United States

  • Seattle Cancer Care Alliance, Seattle, Washington, United States

  • Froedtert & Medical College of Wisconsin, Milwaukee, Wisconsin, United States

  • Eastern Health - Health Sciences Centre, St. John's, Newfoundland and Labrador, Canada

  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada

  • Fakultni Nemocnice Ostrava, Ostrava, Moravian-Silesian, Czechia

  • Fakultní Nemocnice Královské Vinohrady, Prague, Prague, Czechia

  • Vseobecna Fakultni Nemocnice v Praze, Prague, Prague, Czechia

  • Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole, Toulouse, Haute-Garonne, France

  • Hôpital l'Archet, Nice, Provence-Alpes-Côte d'Azur Region, France

  • Hôpital Saint-Louis, Paris, Île-de-France Region, France

  • Universitätsklinikum Freiburg, Freiburg im Breisgau, Baden-Wurttemberg, Germany

  • Universitätsklinikum Heidelberg, Heidelberg, Baden-Wurttemberg, Germany

  • Städtisches Klinikum Braunschweig, Braunschweig, Lower Saxony, Germany

  • Universitätsklinikum Halle, Halle, Saxony-Anhalt, Germany

  • Szent-Györgyi Albert Klinikai Központ, II. sz. Belgyógyászati Klinika és Kardiológiai Központ, Szeged, Csongrád megye, Hungary

  • Petz Aladár Győr-Moson-Sopron Vármegyei Egyetemi Oktató Kórház, Győr, Győr-Moson-Sopron, Hungary

  • Debreceni Egyetem Klinikai Központ, Debrecen, Hajdú-Bihar, Hungary

  • Semmelweis Egyetem Belgyógyászati és Hematológiai Klinika, Budapest, Hungary

  • Ospedale Santa Maria delle Croci di Ravenna, Ravenna, Emilia-Romagna, Italy

  • Azienda Ospedaliero - Universitaria Careggi, Florence, Florence, Italy

  • Azienda Ospedaliera Ordine Mauriziano di Torino, Torino, Turin, Italy

  • Azienda Ospedaliero-Universitaria di Bologna - Policlinico Sant Orsola-Malpighi, Bologna, Italy

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

  • Azienda Ospedaliero-Universitaria Maggiore della Carità di Novara, Novara, Italy

  • Fondazione PTV - Policlinico Tor Vergata, Roma, Italy

  • Umberto I - Policlinico di Roma, Roma, Italy

  • Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino, Torino, Italy

  • Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie, Lublin, Lublin Voivodeship, Poland

  • Wojewódzkie Wielospecjalistyczne Centrum, Lodz, Lódzkie, Poland

  • Szpitale Pomorskie Spółka Z Ograniczoną Odpowiedzialnością, Gdynia, Pomeranian Voivodeship, Poland

  • Institut Català d'Oncologia Badalona, Badalona, Barcelona, Spain

  • Institut Català d'Oncologia - Hospital Duran i Reynals (ICO L'Hospitalet), L'Hospitalet de Llobregat, Barcelona, Spain

  • Clinica Universidad de Navarra - Pamplona, Pamplona, Navarre, Spain

  • Hospital Universitario Central de Asturias, Oviedo, Principality of Asturias, Spain

  • Hospital Universitari Vall d'Hebrón, Barcelona, Spain

  • Hospital Clinic de Barcelona, Barcelona, Spain

  • Hospital San Pedro de Alcantara, Cáceres, Spain

  • Institut Català d'Oncologia Girona (ICO Girona), Girona, Spain

  • Hospital Universitario Virgen de las Nieves, Granada, Spain

  • Hospital General Universitario Gregorio Marañón, Madrid, Spain

  • Clínica Universidad de Navarra - Madrid, Madrid, Spain

  • MD Anderson Cancer Center Madrid, Madrid, Spain

  • Hospital Universitario La Paz, Madrid, Spain

  • Hospital Quirónsalud Málaga, Málaga, Spain

  • Complejo Asistencial Universitario de Salamanca - Hospital Clínico, Salamanca, Spain

  • Hospital Universitari i Politècnic La Fe, Valencia, Spain

  • King's College Hospital NHS Foundation Trust, London, England, United Kingdom

  • The Christie NHS Foundation Trust, Manchester, England, United Kingdom

  • University Hospital Southampton NHS Foundation Trust, Southampton, England, United Kingdom